A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women ; day:15 ; month:3 ; year:2017 ; pages:1-14
Breast cancer research and treatment ; (15.3.2017), 1-14
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Tseng, Ling-Ming
- Beteiligte Personen und Organisationen
-
Chiu, Jen-hwey
Liu, Chun-Yu
Tsai, Yi-Fang
Wang, Yun-Lin
Yang, Chu-Wen
Shyr, Yi-Ming
SpringerLink (Online service)
- DOI
-
10.1007/s10549-017-4195-7
- URN
-
urn:nbn:de:1111-201704046572
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tseng, Ling-Ming
- Chiu, Jen-hwey
- Liu, Chun-Yu
- Tsai, Yi-Fang
- Wang, Yun-Lin
- Yang, Chu-Wen
- Shyr, Yi-Ming
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
Metastatic Triple-Negative Breast Cancer
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
Metastatic Triple-Negative Breast Cancer
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Advances in immunotherapy for triple-negative breast cancer
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
Metastatic Triple-Negative Breast Cancer
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer
MicroRNA signatures in triple-negative breast cancer
Immune-related biomarkers in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer